Therefore, it is not surprising that the expression of SOX4 is increased in various malignancies, including breast, prostate, stomach, and colon cancer, and that it acts as an oncogene [44–46] which was not confirmed in the present study. Here, SOX4 is linked to malignant colon neoplasm.